OTCMKTS:LHDXQ Lucira Health (LHDXQ) Stock Forecast, Price & News $0.0002 0.00 (0.00%) (As of 09/21/2023 ET) Add Compare Share Share Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.00▼$1.45Volume43 shsAverage Volume6,802 shsMarket Capitalization$8,120.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort Interest About Lucira Health (OTCMKTS:LHDXQ) StockLucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and changed its name to Lucira Health, Inc. in January 2020. Lucira Health, Inc. was incorporated in 2013 and is headquartered in Emeryville, California. On February 22, 2023, Lucira Health, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.Read More LHDXQ Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LHDXQ Stock News HeadlinesSeptember 20, 2023 | msn.comU.S. govt. to restart program to ship free at-home COVID testsAugust 3, 2023 | forbes.comBest Senior Dating Sites Of 2023September 22, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.April 28, 2023 | benzinga.comRemember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction BidApril 20, 2023 | marketwatch.com8-K: Lucira Health, Inc.April 11, 2023 | bizjournals.comBankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to PfizerApril 7, 2023 | bizjournals.comPfizer to buy Covid-flu test developer Lucira Health out of bankruptcy courtApril 6, 2023 | wsj.comFirm Retention Summary: Lucira Health Inc.September 22, 2023 | Chaikin Analytics (Ad)This is the #1 Stock to Buy for the AI Tidal WaveMarc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.March 29, 2023 | marketwatch.comLucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale ProcessMarch 20, 2023 | investing.comLucira Health Inc (LHDXQ)March 18, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 17, 2023 | seekingalpha.comLHDXQ Lucira Health, Inc.March 10, 2023 | finance.yahoo.comFDA Addresses 'Misinformation' Concerning Delayed Approval Of Lucira Health's COVID-19 & Flu Home TestMarch 8, 2023 | bizjournals.comCovid-flu test fell short of number of flu samples, FDA says in explaining delayMarch 8, 2023 | bizjournals.comFDA fires back at claims of long delay in approving combined Covid-flu testMarch 7, 2023 | finance.yahoo.comUPDATE 1-Lucira's home test for flu and COVID-19 gets U.S. FDA nod for OTC useMarch 7, 2023 | finance.yahoo.comFDA Approval Brings Some Good News For Bankrupt Lucira HealthMarch 3, 2023 | investorplace.comWhy Is Lucira Health (LHDX) Stock Down 14% Today?February 28, 2023 | benzinga.comShort Volatility Alert: Lucira Health IncFebruary 28, 2023 | msn.comLucira Soars on FDA Approval of COVID-19 and Flu TestFebruary 27, 2023 | finance.yahoo.comLucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy FilingFebruary 27, 2023 | msn.comLucira Health is Soaring Monday: Here Are The DetailsFebruary 27, 2023 | rttnews.comFDA Authorizes First At-Home Test To Detect Flu And COVID-19 February 24, 2023 | bizjournals.comDelay with Covid-flu test sent East Bay company to Chapter 11. Regulators OK it — two days laterFebruary 24, 2023 | finance.yahoo.comLucira stock more than doubles after hours on FDA OK for COVID-19, flu testFebruary 24, 2023 | seekingalpha.comLucira Health to sell business and file Chapter 11 bankruptcy; shares down 7%See More Headlines Receive LHDXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter. Email Address LHDXQ Company Calendar Last Earnings11/11/2021Today9/22/2023Next Earnings (Estimated)10/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:LHDXQ CUSIPN/A CIK1652724 Webwww.lucirahealth.com Phone510-350-8071FaxN/AEmployees221Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$93.06 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book0.00Miscellaneous Outstanding Shares40,600,000Free Float28,257,000Market Cap$8,120.00 OptionableOptionable Beta2.39 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesGreg ChodaczekInvestor RelationsDr. Nadine Greiner Ph.D.Chief HR OfficerKey CompetitorsFluoroPharma MedicalOTCMKTS:FPMIGlobal WholeHealth PartnersOTCMKTS:GWHPE-QureOTCMKTS:EQURCVR MedicalOTCMKTS:CRRVFGenocea BiosciencesNASDAQ:GNCAQView All CompetitorsInsidersGhazi KashmolahSold 5,028 sharesTotal: $1,357.56 ($0.27/share)Anthony Joseph AllenSold 4,263 sharesTotal: $682.08 ($0.16/share)Ghazi KashmolahSold 7,537 sharesTotal: $3,165.54 ($0.42/share)Kevin Walter CollinsSold 9,666 sharesTotal: $4,059.72 ($0.42/share)Anthony Joseph AllenSold 34,429 sharesTotal: $11,361.57 ($0.33/share)View All Insider Transactions LHDXQ Stock - Frequently Asked Questions How have LHDXQ shares performed in 2023? Lucira Health's stock was trading at $0.5490 at the beginning of 2023. Since then, LHDXQ shares have decreased by 100.0% and is now trading at $0.0002. View the best growth stocks for 2023 here. When is Lucira Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 2nd 2023. View our LHDXQ earnings forecast. How were Lucira Health's earnings last quarter? Lucira Health, Inc. (OTCMKTS:LHDXQ) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.51) by $0.04. The business earned $14.98 million during the quarter, compared to analyst estimates of $18 million. What is Lucira Health's stock symbol? Lucira Health trades on the OTCMKTS under the ticker symbol "LHDXQ." How do I buy shares of Lucira Health? Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Lucira Health's stock price today? One share of LHDXQ stock can currently be purchased for approximately $0.00. How much money does Lucira Health make? Lucira Health (OTCMKTS:LHDXQ) has a market capitalization of $8,120.00 and generates $93.06 million in revenue each year. The company earns $-64,830,000.00 in net income (profit) each year or ($3.58) on an earnings per share basis. How many employees does Lucira Health have? The company employs 221 workers across the globe. How can I contact Lucira Health? Lucira Health's mailing address is 1412 62ND STREET, EMERYVILLE CA, 94608. The official website for the company is www.lucirahealth.com. The company can be reached via phone at 510-350-8071. This page (OTCMKTS:LHDXQ) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucira Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.